Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare Biotechnology
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd > Shareholders “letters” interesting
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(137)
•••
Comment by DavidRosenbergon Nov 02, 2021 6:00pm
46 Views
Post# 34079580

RE:Shareholders “letters” interesting

RE:Shareholders “letters” interesting
GrahamB wrote: Read the comments at the bottom of the webpage regarding the successful lawsuit against FSD
Know that the past experiences with management can be helpful in judging the future success of the company 


https://thedeepdive.ca/fsd-pharma-ends-class-action-lawsuit-with-5-5-million-settlement/



Great so should we sell all our shares because of that? 

Should we not care about psychedelic space anymore or the new things they are working on , should we keep spamming about the lawsuit settlement from the past with Raza Bokhari as CEO at the time?
 What do you advise we should do graham sell all of our shares?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities